Rosuvastatin NOBEL 5 mg
Rosuvastatin NOBEL 5 mg is a medicine authorised by Swissmedic under authorisation number 67605. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 December 2019 and the authorisation is valid without a time limit. ATC code C10AA07 places the medicine in the group Lipid modifying agents.
| Authorisation number | 67605 |
|---|---|
| Name | Rosuvastatin NOBEL 5 mg |
| Full name | Rosuvastatin NOBEL 5 mg, Filmtabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C10AA07 |
| First authorisation | 16 December 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rosuvastatin NOBEL 5 mg, Filmtabletten | B | 16 December 2019 |
| 2 | Rosuvastatin NOBEL 10 mg, Filmtabletten | B | 16 December 2019 |
| 3 | Rosuvastatin NOBEL 20 mg, Filmtabletten | B | 16 December 2019 |
| 4 | Rosuvastatin NOBEL 40 mg, Filmtabletten | B | 16 December 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 2 | 105 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 9 | 190 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 3 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 4 | 105 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 10 | 190 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 5 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 6 | 105 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 11 | 120 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 7 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 8 | 105 | Tablette(n) | C10AA07 | 07.12.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rosuvastatin NOBEL 5 mg authorised in Switzerland?
Yes. Rosuvastatin NOBEL 5 mg is authorised by Swissmedic under authorisation number 67605, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rosuvastatin NOBEL 5 mg have?
Rosuvastatin NOBEL 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rosuvastatin NOBEL 5 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.